Vane, "Group R & D Strategy - Volume 3"
- Date:
- 1984
- Reference:
- WF/E/13/95
- Part of:
- Wellcome Foundation Ltd
- Archives and manuscripts
About this work
Description
Volume 3 of "Group R & D Strategy"comprising Appendices 15-23, as follows.
15. Group R & D Strategy Statement, Selsdon Park (6 July 1984).
16. Business Week - "A deepening commitment to R & D" (1984).
17. Scrip - "Leading Pharmaceutical Companies, 1982-83" (1983).
18. New Product Introductions. Lists A, B, C.
19. Burroughs Wellcome Co: Five-year Comparison of Selected Drug Industry Data (30 April 1984).
20. Formulations of Septrin, Zyloric, "Feds" and Zovirax available.
21. Range extensions under consideration for major products in Europe.
22. Product ideas currently under active discussion with UK Company.
23. Drug delivery systems.
15. Group R & D Strategy Statement, Selsdon Park (6 July 1984).
16. Business Week - "A deepening commitment to R & D" (1984).
17. Scrip - "Leading Pharmaceutical Companies, 1982-83" (1983).
18. New Product Introductions. Lists A, B, C.
19. Burroughs Wellcome Co: Five-year Comparison of Selected Drug Industry Data (30 April 1984).
20. Formulations of Septrin, Zyloric, "Feds" and Zovirax available.
21. Range extensions under consideration for major products in Europe.
22. Product ideas currently under active discussion with UK Company.
23. Drug delivery systems.
Document dated August 1984.
Publication/Creation
1984
Physical description
1 file 25 sheets, plus 2 card cover sheets.
Copyright note
Copyright assigned to the Wellcome Trust
Where to find it
Location Status Access Closed stores